Today we are excited to make two big announcements! First, we have launched a new collaboration with Microsoft! This collaboration includes access to the computing resources we need to power our novel drug discovery platform and to scale our generative AI models. And speaking of models, the second announcement is that we’ve released the details of our Foundation Model, PRISM (Pretrained Representations Informed by Spectral Masking). PRISM takes advantage of the latest advancements in machine learning that let models learn from unlabeled data. This allowed us to train it on the largest dataset of mass spectra ever assembled – over one billion! – which has improved our ability to translate cryptic mass spectra data into predictions of chemical structures and properties. These predictions point our chemists to the most attractive and amenable molecules in nature to turn into new, impactful medicines. For more details on the collaboration, check out the press release: https://bit.ly/450dnGE And to learn about PRISM, please read our blog post: https://lnkd.in/g3UMiTA4
Smashing it as always - v exciting 💥
Congrats Viswa Colluru, PhD and team Enveda Biosciences, this is fantastic
Way to go!
Great news! Inspiring
Congrats to Viswa Colluru, PhD and the Enveda Biosciences team!
Congratulations!
Congratulations!
Incredible !! Congratulations to you Jason Tejani and Team👍
Congratulations!
Senior Vice-President, Early Development. Enveda BioSciences
1moCongrats to the Data Sciences team on this success. 👏👏